Cargando…
DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening
Ornithine decarboxylase (ODC), the first rate-limiting enzyme in polyamine synthesis, has emerged as a therapeutic target for cancer and Alzheimer’s disease (AD). To inhibit ODC, α-difluoromethylornithine (DFMO), an irreversible ODC inhibitor, has been widely used. However, due to its poor pharmacok...
Autores principales: | Park, Mingu Gordon, Kim, Suyeon Yellena, Lee, C. Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721421/ https://www.ncbi.nlm.nih.gov/pubmed/36451618 http://dx.doi.org/10.1080/14756366.2022.2150186 |
Ejemplares similares
-
Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017) -
Polyamine biosynthesis in Xenopus laevis: the xlAZIN2/xlODC2 gene encodes a lysine/ornithine decarboxylase
por: Lambertos, Ana, et al.
Publicado: (2019) -
Chloroform induction of ornithine decarboxylase activity in rats.
por: Savage, R E, et al.
Publicado: (1982) -
Downregulation of tumstatin expression by overexpression of ornithine decarboxylase
por: WANG, WEI, et al.
Publicado: (2013) -
Metabolic Characterization of Hyoscyamus niger Ornithine Decarboxylase
por: Zhao, Tengfei, et al.
Publicado: (2019)